Home Instil Bio

Instil Bio

In operation
IPO
Clinical-stage cell therapy developer
Basic
Enterprise Profile

Basic Information

Instil Bio, Inc. is a global clinical-stage cell therapy company dedicated to developing tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Building on decades of foundational work using TIL to treat solid tumors, we leverage our cell therapy expertise and TIL manufacturing platform to bring the promise of TIL therapy to patients in need.
Instil Bio, Inc.
Dallas,Texas,United States of America
101~500 people
January 01, 2018
--

Enterprise Profile

Industrial Sector
New Drug Development Manufacture of Biological Pharmaceutical Products Immune Cell Therapy
Technology
Immunological Techniques Cell Technology
Concept
Therapeutic Products Ovarian Cancer Lymphoma
Application Scenarios
Biologics Innovative Drugs